Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yinghui Zhou

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Pharmaceutical Statistics|November 4, 2006
Bayesian decision procedures for binary and continuous bivariate dose-escalation studiesYinghui Zhou, John Whitehead, Elisa Bonvini, et al.
The Journal of Chemical Physics|October 5, 2010
Atomic structure and formation mechanism of identically sized Au clusters grown on Si(111)-(7×7) surfaceYaping Wu, Yinghui Zhou, Changjie Zhou, et al.
Statistics in Medicine|January 7, 2006
Sequential genome-wide association studies for monitoring adverse events in the clinical evaluation of new drugsPatrick Kelly, Nigel Stallard, Yinghui Zhou, et al.
Statistics in Medicine|November 6, 2007
Sequentially testing for a gene-drug interaction in a genomewide analysisPatrick Kelly, Yinghui Zhou, John Whitehead, et al.
Journal of Biopharmaceutical Statistics|November 21, 2007
A Bayesian approach for dose-escalation in a Phase I clinical trial incorporating pharmacodynamic endpointsJohn Whitehead, Yinghui Zhou, Lisa Hampson, et al.
Journal of Bioscience and Bioengineering|December 13, 2024
Development of in vitro hair pigmentation model using hair follicle organoidsShan Tu, Tatsuto Kageyama, Jieun Seo, et al.
Pharmaceutical Statistics|November 6, 2007
Fitting models for the joint action of two drugs using SASAnne Whitehead, John Whitehead, Susan Todd, et al.
Hybridoma (2005)|December 8, 2010
Epitope analysis and antibody preparation of human polypeptide:N-acetylgalactosaminyltransferase-2 proteinLan Xu, Guangbo Zhang, Hao Qiu, et al.
Pharmaceutical Statistics|December 17, 2008
Action following the discovery of a global association between the whole genome and adverse event risk in a clinical drug-development programmeJohn Whitehead, Patrick Kelly, Yinghui Zhou, et al.
Hybridoma (2005)|December 14, 2011
An anti-human ppGalNAcT-2 monoclonal antibodyChunliang Liu, Dandan Lin, Lan Xu, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Pharmaceutical Statistics|November 4, 2006
Bayesian decision procedures for binary and continuous bivariate dose-escalation studiesYinghui Zhou, John Whitehead, Elisa Bonvini, et al.
The Journal of Chemical Physics|October 5, 2010
Atomic structure and formation mechanism of identically sized Au clusters grown on Si(111)-(7×7) surfaceYaping Wu, Yinghui Zhou, Changjie Zhou, et al.
Statistics in Medicine|January 7, 2006
Sequential genome-wide association studies for monitoring adverse events in the clinical evaluation of new drugsPatrick Kelly, Nigel Stallard, Yinghui Zhou, et al.
Statistics in Medicine|November 6, 2007
Sequentially testing for a gene-drug interaction in a genomewide analysisPatrick Kelly, Yinghui Zhou, John Whitehead, et al.
Journal of Biopharmaceutical Statistics|November 21, 2007
A Bayesian approach for dose-escalation in a Phase I clinical trial incorporating pharmacodynamic endpointsJohn Whitehead, Yinghui Zhou, Lisa Hampson, et al.
Journal of Bioscience and Bioengineering|December 13, 2024
Development of in vitro hair pigmentation model using hair follicle organoidsShan Tu, Tatsuto Kageyama, Jieun Seo, et al.
Pharmaceutical Statistics|November 6, 2007
Fitting models for the joint action of two drugs using SASAnne Whitehead, John Whitehead, Susan Todd, et al.
Hybridoma (2005)|December 8, 2010
Epitope analysis and antibody preparation of human polypeptide:N-acetylgalactosaminyltransferase-2 proteinLan Xu, Guangbo Zhang, Hao Qiu, et al.
Pharmaceutical Statistics|December 17, 2008
Action following the discovery of a global association between the whole genome and adverse event risk in a clinical drug-development programmeJohn Whitehead, Patrick Kelly, Yinghui Zhou, et al.
Hybridoma (2005)|December 14, 2011
An anti-human ppGalNAcT-2 monoclonal antibodyChunliang Liu, Dandan Lin, Lan Xu, et al.
Pageof 12